New Zealand Regulatory Update
March 2026
The Government is currently seeking feedback on a proposal to increase the amount of vitamin D permitted in a general sale medicine.
At present, general sale medicines can contain up to 25 micrograms (1,000 IU) of vitamin D per daily dose. The consultation proposes increasing this limit to 50 micrograms (2,000 IU) per daily dose.
We encourage you to share your views and provide feedback.
The deadline is 2 April.
Natural Health Products Bill
The Ministry of Health is developing a standalone Natural Health Products Bill to create a dedicated regulatory framework for natural health products following the repeal of the Therapeutic Products Act 2023.
As of March 2026, the bill has not yet been introduced to Parliament and no timeline for its passage has been confirmed.
Our commitment:
FxMed will be working closely with the Natural Health Alliance (NHA). Together with the NHA, we are committed to ensuring sensible, risk-proportionate legislation.
What can you do?
Throughout the engagement process for the new Bill for Natural Health Products, we encourage you to make your feelings known to any industry organisations that you belong to, your local MPs plus the Minister and their team.
Brief timeline of key regulatory events
The Government announced it will be introducing legislation to amend the Health Practitioners Competence Assurance Act 2003.
Read the press release from Minister of Health, Hon Simeon Brown: Health workforce regulations to put patients first.
The aim of these changes is to ensure health workforce regulation aligns with patient needs, health system priorities and the Government’s health targets.
Next steps
The Ministry of Health will now support the Government with drafting legislation for a bill. The bill is expected to be introduced to Parliament in the months ahead.